Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the nine research firms that are covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $50.39.
Several brokerages have recently commented on ACHC. Mizuho decreased their price target on Acadia Healthcare from $48.00 to $37.00 and set a "neutral" rating on the stock in a research note on Tuesday, March 25th. Barclays lowered shares of Acadia Healthcare from an "overweight" rating to an "equal weight" rating and lowered their target price for the stock from $43.00 to $35.00 in a research note on Friday, February 28th. Bank of America reduced their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research note on Friday, February 28th. KeyCorp lowered their price objective on shares of Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating for the company in a research report on Monday, March 3rd. Finally, StockNews.com cut Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Monday, January 6th.
Read Our Latest Stock Analysis on ACHC
Acadia Healthcare Trading Down 6.9 %
Shares of NASDAQ ACHC traded down $2.02 during midday trading on Friday, reaching $27.08. 3,211,674 shares of the stock were exchanged, compared to its average volume of 1,464,275. Acadia Healthcare has a twelve month low of $25.41 and a twelve month high of $82.41. The stock has a market capitalization of $2.52 billion, a P/E ratio of 8.88, a PEG ratio of 1.46 and a beta of 1.13. The company has a 50 day simple moving average of $33.60 and a 200 day simple moving average of $41.53. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of the stock. Treasurer of the State of North Carolina boosted its stake in shares of Acadia Healthcare by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company's stock valued at $1,586,000 after buying an additional 250 shares during the period. Nisa Investment Advisors LLC lifted its stake in Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock worth $41,000 after acquiring an additional 301 shares during the last quarter. Coldstream Capital Management Inc. grew its holdings in Acadia Healthcare by 4.9% during the 4th quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company's stock worth $257,000 after acquiring an additional 303 shares in the last quarter. Covestor Ltd increased its position in shares of Acadia Healthcare by 27.2% in the 4th quarter. Covestor Ltd now owns 1,450 shares of the company's stock valued at $58,000 after purchasing an additional 310 shares during the last quarter. Finally, Pacer Advisors Inc. raised its holdings in shares of Acadia Healthcare by 2.4% in the 4th quarter. Pacer Advisors Inc. now owns 13,847 shares of the company's stock valued at $549,000 after purchasing an additional 325 shares in the last quarter.
Acadia Healthcare Company Profile
(
Get Free ReportAcadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Further Reading

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.